WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study

doi:10.21873/anticanres.12464

WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study

Anticancer Research ◽

10.21873/anticanres.12464 ◽

2018 ◽

Vol 38 (4) ◽

Cited By ~ 9

Keyword(s):

Pancreatic Cancer ◽

Dendritic Cell ◽

Phase I ◽

Phase I Study ◽

Dendritic Cell Vaccine ◽

Cell Vaccine

Download Full-text

A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent Glioblastoma

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-21-2867 ◽

2021 ◽

pp. clincanres.2867.2021

Author(s):

Jethro L. Hu ◽

Oluwaseun A. Omofoye ◽

Jeremy D. Rudnick ◽

Sungjin Kim ◽

Mourad Tighiouart ◽

...

Keyword(s):

Dendritic Cell ◽

Phase I ◽

Cell Line ◽

Phase I Study ◽

Dendritic Cell Vaccine ◽

Recurrent Glioblastoma ◽

Cell Vaccine ◽

Newly Diagnosed ◽

Autologous Dendritic Cell

Download Full-text

Faculty Opinions recommendation of Clinical outcome of immunotherapy with dendritic cell vaccine and cytokine-induced killer cell therapy in hepatobiliary and pancreatic cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727595480.793531790 ◽

2017 ◽

Author(s):

John Nemunaitis ◽

Luisa Manning

Keyword(s):

Pancreatic Cancer ◽

Dendritic Cell ◽

Clinical Outcome ◽

Cell Therapy ◽

Killer Cell ◽

Dendritic Cell Vaccine ◽

Cell Vaccine

Download Full-text

Abstract CT016: A first in man phase I/II adjuvant dendritic cell vaccine study in high-risk prostate cancer patients following radical surgery reduce the incidence of biochemical relapse

10.1158/1538-7445.am2018-ct016 ◽

2018 ◽

Author(s):

Anne Merete Tryggestad ◽

Iris Bigalke ◽

Karol Axcrona ◽

Bjørn Brennhovd ◽

T Kirsti Hønnåshagen ◽

...

Keyword(s):

Prostate Cancer ◽

Dendritic Cell ◽

High Risk ◽

Phase I ◽

Radical Surgery ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

Biochemical Relapse ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

Download Full-text

Results from a first in man Phase I/II adjuvant Dendritic Cell Vaccine study in high risk prostate cancer patients following radical surgery

Cytotherapy ◽

10.1016/j.jcyt.2017.02.025 ◽

2017 ◽

Vol 19 (5) ◽

pp. S15 ◽

Cited By ~ 1

Author(s):

A.A. Tryggestad ◽

I. Bigalke ◽

K. Axcrona ◽

E. Inderberg ◽

G. Skorstad ◽

...

Keyword(s):

Prostate Cancer ◽

Dendritic Cell ◽

High Risk ◽

Phase I ◽

Cancer Patients ◽

Radical Surgery ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

Download Full-text

LPS-activated dendritic cell vaccine in combination with immunomodulatory dose of cytoxan in patients with stage IV melanoma: Phase I/IIa clinical trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.tps313 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS313-TPS313 ◽

Cited By ~ 1

Author(s):

A. K. Palucka ◽

H. Ueno ◽

J. W. Fay ◽

J. Banchereau

Keyword(s):

Clinical Trial ◽

Dendritic Cell ◽

Phase I ◽

Stage Iv ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

Stage Iv Melanoma

Download Full-text

Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy

Journal of Clinical Neuroscience ◽

10.1016/j.jocn.2007.08.007 ◽

2008 ◽

Vol 15 (2) ◽

pp. 114-121 ◽

Cited By ~ 50

Author(s):

David G. Walker ◽

Richard Laherty ◽

Frank H. Tomlinson ◽

Teong Chuah ◽

Chris Schmidt

Keyword(s):

Dendritic Cell ◽

Adjuvant Chemotherapy ◽

Phase I ◽

Vaccine Trial ◽

Dendritic Cell Vaccine ◽

Potential Interaction ◽

Cell Vaccine ◽

Malignant Astrocytoma

Download Full-text

Clinical outcome of immunotherapy with dendritic cell vaccine and cytokine-induced killer cell therapy in hepatobiliary and pancreatic cancer

Molecular and Clinical Oncology ◽

10.3892/mco.2015.660 ◽

2015 ◽

Vol 4 (1) ◽

pp. 129-133 ◽

Cited By ~ 9

Author(s):

LIHONG ZHANG ◽

WEI ZHU ◽

JIALI LI ◽

XUEJING YANG ◽

YANJIE REN ◽

...

Keyword(s):

Pancreatic Cancer ◽

Dendritic Cell ◽

Clinical Outcome ◽

Cell Therapy ◽

Killer Cell ◽

Dendritic Cell Vaccine ◽

Cell Vaccine

Download Full-text

LPS activated dendritic cell vaccine in combination with immunomodulatory dose of cyclophosphamide in patients with stage IV melanoma: Preliminary report from the phase I/IIa clinical trial

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.3049 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 3049-3049

Author(s):

A. K. Palucka ◽

E. Akagawa ◽

H. Ueno ◽

J. Fay ◽

J. Banchereau

Keyword(s):

Clinical Trial ◽

Dendritic Cell ◽

Phase I ◽

Preliminary Report ◽

Stage Iv ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

Stage Iv Melanoma

Download Full-text

Abstract 2813: Survival benefit of an add-on dendritic cell vaccine for patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter study

10.1158/1538-7445.am2014-2813 ◽

2014 ◽

Author(s):

Masanori Kobayashi ◽

Shimodaira Shigetaka ◽

Kazuhiro Nagai ◽

Masahiro Ogasawara ◽

Hidenori Takahashi ◽

...

Keyword(s):

Pancreatic Cancer ◽

Dendritic Cell ◽

Multicenter Study ◽

Survival Benefit ◽

Dendritic Cell Vaccine ◽

Cell Vaccine

Download Full-text

Abstract A16: A phase I/II clinical trial of a MUC1-glycopeptide dendritic cell vaccine in castrate resistant non-metastatic prostate cancer patients

Cancer Research ◽

10.1158/1538-7445.prca2012-a16 ◽

2012 ◽

Vol 72 (4 Supplement) ◽

pp. A16-A16 ◽

Cited By ~ 1

Author(s):

Pierre Major ◽

Louis Lacombe ◽

Yves Fradet ◽

Ronan Foley ◽

Elizabeth Scheid ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Dendritic Cell ◽

Phase I ◽

Cancer Patients ◽

Metastatic Prostate Cancer ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

Castrate Resistant

Download Full-text